The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter phase II study of the efficacy and safety of quisinostat (an HDAC inhibitor) in combination with paclitaxel and carboplatin chemotherapy (CT) in patients (pts) with recurrent platinum resistant high grade serous epithelial ovarian, primarily peritoneal or fallopian tube carcinoma cancer (OC).
 
Sergei Tjulandin
Stock and Other Ownership Interests - RosPharmTech
Speakers' Bureau - AstraZeneca; Lilly; Sanofi
Travel, Accommodations, Expenses - Boehringer Ingelheim; Roche
 
Mikhail Fedyanin
No Relationships to Disclose
 
Vladimir Ivanovich Vladimirov
No Relationships to Disclose
 
Vladimir Kostorov
No Relationships to Disclose
 
Alla Sergeevua Lisyanskaya
No Relationships to Disclose
 
Ludmila Krikunova
No Relationships to Disclose
 
Andrew Cakana
Employment - Janssen
 
Valeria Azarova
Employment - IPD-Therapeutics
 
Oksana Karavaeva
Employment - IPD-Therapeutics
 
Natalia Vostokova
Employment - IPD-Therapeutics
 
Sergey Baranovsky
Employment - NewVac, LLC